| Year |
Citation |
Score |
| 2020 |
Cook IA, Hunter AM, Caudill MM, Abrams MJ, Leuchter AF. Prospective testing of a neurophysiologic biomarker for treatment decisions in major depressive disorder: The PRISE-MD trial. Journal of Psychiatric Research. 124: 159-165. PMID 32169689 DOI: 10.1016/J.Jpsychires.2020.02.028 |
0.466 |
|
| 2019 |
Fung CH, Martin JL, Alessi C, Dzierzewski JM, Cook IA, Moore A, Grinberg A, Zeidler M, Kierlin L. Hypnotic Discontinuation Using a Blinded (Masked) Tapering Approach: A Case Series. Frontiers in Psychiatry. 10: 717. PMID 31708806 DOI: 10.3389/Fpsyt.2019.00717 |
0.34 |
|
| 2019 |
Cook IA, Congdon E, Krantz DE, Hunter AM, Coppola G, Hamilton SP, Leuchter AF. Time Course of Changes in Peripheral Blood Gene Expression During Medication Treatment for Major Depressive Disorder. Frontiers in Genetics. 10: 870. PMID 31620172 DOI: 10.3389/Fgene.2019.00870 |
0.346 |
|
| 2019 |
Levitt JG, Kalender G, O’Neill J, Diaz JP, Cook IA, Ginder N, Krantz D, Minzenberg MJ, Vince-Cruz N, Nguyen LD, Alger JR, Leuchter AF. Dorsolateral prefrontal γ-aminobutyric acid in patients with treatment-resistant depression after transcranial magnetic stimulation measured with magnetic resonance spectroscopy Journal of Psychiatry & Neuroscience : Jpn. 44: 1-9. PMID 31199104 DOI: 10.1503/Jpn.180230 |
0.34 |
|
| 2019 |
Corlier J, Wilson A, Hunter AM, Vince-Cruz N, Krantz D, Levitt J, Minzenberg MJ, Ginder N, Cook IA, Leuchter AF. Changes in Functional Connectivity Predict Outcome of Repetitive Transcranial Magnetic Stimulation Treatment of Major Depressive Disorder. Cerebral Cortex (New York, N.Y. : 1991). PMID 30953441 DOI: 10.1016/J.Brs.2018.12.812 |
0.461 |
|
| 2019 |
Hunter AM, Minzenberg MJ, Cook IA, Krantz DE, Levitt JG, Rotstein NM, Chawla SA, Leuchter AF. Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder. Brain and Behavior. e01275. PMID 30941915 DOI: 10.1002/Brb3.1275 |
0.458 |
|
| 2019 |
Cook IA, Wilson AC, Corlier J, Leuchter AF. Brain Activity and Clinical Outcomes in Adults With Depression Treated With Synchronized Transcranial Magnetic Stimulation: An Exploratory Study. Neuromodulation : Journal of the International Neuromodulation Society. PMID 30637862 DOI: 10.1111/Ner.12914 |
0.364 |
|
| 2019 |
Cook IA, Leuchter AF, Witte E, Abrams M, Uijtdehaage SH, Stubbeman W, Rosenberg-Thompson S, Anderson-Hanley C, Dunkin JJ. Corrigendum to 'Neurophysiologic predictors of treatment response to fluoxetine in major depression'. Psychiatry Research. 95: 87. PMID 10904127 DOI: 10.1016/S0165-1781(00)00170-0 |
0.452 |
|
| 2019 |
Cook I, Wilson A, Corlier J, Leuchter A. Brain activity and clinical outcomes in adults with depression treated with synchronized transcranial magnetic stimulation (sTMS): an exploratory study Brain Stimulation. 12: 584-585. DOI: 10.1016/J.Brs.2018.12.941 |
0.416 |
|
| 2018 |
Philip NS, Leuchter AF, Cook IA, Massaro J, Goethe JW, Carpenter LL. Predictors of response to synchronized transcranial magnetic stimulation for major depressive disorder. Depression and Anxiety. PMID 30480860 DOI: 10.1002/Da.22862 |
0.42 |
|
| 2018 |
Shekelle PG, Cook IA, Miake-Lye IM, Booth MS, Beroes JM, Mak S. Benefits and Harms of Cranial Electrical Stimulation for Chronic Painful Conditions, Depression, Anxiety, and Insomnia: A Systematic Review. Annals of Internal Medicine. PMID 29435567 DOI: 10.7326/M17-1970 |
0.388 |
|
| 2017 |
Hunter AM, Nghiem TX, Cook IA, Krantz DE, Minzenberg MJ, Leuchter AF. Change in Quantitative EEG Theta Cordance as a Potential Predictor of Repetitive Transcranial Magnetic Stimulation Clinical Outcome in Major Depressive Disorder. Clinical Eeg and Neuroscience. 1550059417746212. PMID 29224411 DOI: 10.1177/1550059417746212 |
0.471 |
|
| 2017 |
McClintock SM, Reti IM, Carpenter LL, McDonald WM, Dubin M, Taylor SF, Cook IA, O'Reardon J, Husain MM, Wall C, Krystal AD, Sampson SM, Morales O, Nelson BG, Latoussakis V, et al. Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression. The Journal of Clinical Psychiatry. PMID 28541649 DOI: 10.4088/Jcp.16Cs10905 |
0.445 |
|
| 2017 |
Leuchter MK, Donzis EJ, Cepeda C, Hunter AM, Estrada-Sánchez AM, Cook IA, Levine MS, Leuchter AF. Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington's Disease: Are They Fit-for-Purpose for Treatment Development? Frontiers in Neurology. 8: 91. PMID 28424652 DOI: 10.3389/Fneur.2017.00091 |
0.346 |
|
| 2017 |
Kobayashi B, Cook IA, Hunter AM, Minzenberg MJ, Krantz DE, Leuchter AF. Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder? International Review of Psychiatry (Abingdon, England). 1-17. PMID 28362541 DOI: 10.1080/09540261.2017.1297697 |
0.452 |
|
| 2017 |
Leuchter A, Corlier J, Cook I. O16 Shifts in mean peak oscillatory frequency during repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder Clinical Neurophysiology. 128: e185. DOI: 10.1016/J.Clinph.2017.07.027 |
0.441 |
|
| 2017 |
Leuchter A, Espinoza R, Suthana N, Hunter A, Cook I. Synergistic effects of ketamine and theta burst stimulation in the treatment of major depressive disorder (MDD) Brain Stimulation. 10: 492. DOI: 10.1016/J.Brs.2017.01.438 |
0.464 |
|
| 2016 |
Leuchter AF, Hunter AM, Jain FA, Tartter M, Crump C, Cook IA. Escitalopram but not placebo modulates brain rhythmic oscillatory activity in the first week of treatment of Major Depressive Disorder. Journal of Psychiatric Research. 84: 174-183. PMID 27770740 DOI: 10.1016/J.Jpsychires.2016.10.002 |
0.409 |
|
| 2016 |
Trevizol AP, Shiozawa P, Cook IA, Sato IA, Kaku CB, Guimarães FB, Sachdev P, Sarkhel S, Cordeiro Q. Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: An Updated Systematic Review and Meta-analysis. The Journal of Ect. PMID 27327557 DOI: 10.1097/Yct.0000000000000335 |
0.3 |
|
| 2016 |
Trevizol AP, Sato IA, Cook IA, Shiozawa P, Lowenthal R, Cordeiro Q. Trigeminal nerve stimulation (TNS) for posttraumatic stress disorder and major depressive disorder: An open-label proof-of-concept trial. Epilepsy & Behavior : E&B. PMID 27177991 DOI: 10.1016/J.Yebeh.2016.04.014 |
0.386 |
|
| 2016 |
Scanlon GC, Jain FA, Hunter AM, Cook IA, Leuchter AF. Neurophysiologic Correlates of Headache Pain in Subjects With Major Depressive Disorder. Clinical Eeg and Neuroscience. PMID 27000108 DOI: 10.1177/1550059416632411 |
0.37 |
|
| 2016 |
Cook IA, Abrams M, Leuchter AF. Trigeminal Nerve Stimulation for Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder. Neuromodulation : Journal of the International Neuromodulation Society. 19: 299-305. PMID 26818103 DOI: 10.1111/Ner.12399 |
0.417 |
|
| 2015 |
Trevizol AP, Shiozawa P, Cook IA, Sato IA, Dos Santos Guimarães FB, Diniz BS, Lowenthal R, Barros MD, Cordeiro Q. Trigeminal Nerve Stimulation (TNS) for Major Depressive Disorder in the Elderly: An Open Label Proof-of-Concept Trial. Brain Stimulation. PMID 26710678 DOI: 10.1016/J.Brs.2015.10.002 |
0.411 |
|
| 2015 |
Trevizol AP, Cordeiro Q, Cook IA, Barros MD, Shiozawa P. Trigeminal Nerve Stimulation (TNS) for the Treatment of Irritable Bowel Syndrome in an Elderly Patient with Major Depressive Disorder: A Case Study. Brain Stimulation. 8: 1235-6. PMID 26433608 DOI: 10.1016/J.Brs.2015.09.001 |
0.414 |
|
| 2015 |
Hunter AM, Cook IA, Tartter M, Sharma SK, Disse GD, Leuchter AF. Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder. Psychopharmacology. PMID 26319158 DOI: 10.1007/S00213-015-4047-2 |
0.457 |
|
| 2015 |
Leuchter AF, Cook IA, Feifel D, Goethe JW, Husain M, Carpenter LL, Thase ME, Krystal AD, Philip NS, Bhati MT, Burke WJ, Howland RH, Sheline YI, Aaronson ST, Iosifescu DV, et al. Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression. Brain Stimulation. 8: 787-94. PMID 26143022 DOI: 10.1016/J.Brs.2015.05.005 |
0.398 |
|
| 2015 |
Cook IA, Kealey CP, DeGiorgio CM. The potential use of trigeminal nerve stimulation in the treatment of epilepsy. Therapeutic Delivery. 6: 273-5. PMID 25853303 DOI: 10.4155/Tde.14.120 |
0.313 |
|
| 2015 |
Leuchter AF, Hunter AM, Krantz DE, Cook IA. Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments. Annals of the New York Academy of Sciences. 1344: 78-91. PMID 25809789 DOI: 10.1111/Nyas.12742 |
0.404 |
|
| 2015 |
Trevizol AP, Shiozawa P, Albuquerque Sato I, da Silva ME, de Barros Calfat EL, Alberto RL, Cook IA, Cordeiro Q. Trigeminal Nerve Stimulation (TNS) for Post-traumatic Stress Disorder: A Case Study. Brain Stimulation. 8: 676-8. PMID 25795622 DOI: 10.1016/J.Brs.2015.02.008 |
0.353 |
|
| 2015 |
Trevizol AP, Shiozawa P, Sato IA, Calfat EL, Alberto RL, Cook IA, Medeiros HH, Cordeiro Q. Trigeminal Nerve Stimulation (TNS) for Generalized Anxiety Disorder: A Case Study. Brain Stimulation. 8: 659-60. PMID 25650095 DOI: 10.1016/J.Brs.2014.12.009 |
0.417 |
|
| 2015 |
Caudill MM, Hunter AM, Cook IA, Leuchter AF. The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder. Clinical Eeg and Neuroscience. 46: 277-84. PMID 25258429 DOI: 10.1177/1550059414532443 |
0.464 |
|
| 2015 |
Cook I, Leuchter A, Jain F, Caudill M, Abrams M, DeGiorgio C. Effects of adjunctive trigeminal nerve stimulation in major depressive disorder in a dose-ranging trial Brain Stimulation. 8: 431. DOI: 10.1016/J.Brs.2015.01.374 |
0.437 |
|
| 2015 |
Leuchter AF, Phillips B, Jin Y, Cook IA, Feifel D, Goethe J, Husain M, Carpenter L, Thase M, Krystal A, Burke W, Howland R, Sheline Y, Jain R, Aaronson S, et al. Safety and Efficacy of Synchronized Transcranial Magnetic Stimulation for the Treatment of Major Depressive Disorder Brain Stimulation. 8: 404. DOI: 10.1016/J.Brs.2015.01.287 |
0.421 |
|
| 2014 |
Leuchter AF, Hunter AM, Krantz DE, Cook IA. Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder. Dialogues in Clinical Neuroscience. 16: 525-37. PMID 25733956 |
0.368 |
|
| 2014 |
Ottaviani C, Shahabi L, Tarvainen M, Cook I, Abrams M, Shapiro D. Cognitive, behavioral, and autonomic correlates of mind wandering and perseverative cognition in major depression. Frontiers in Neuroscience. 8: 433. PMID 25601824 DOI: 10.3389/Fnins.2014.00433 |
0.377 |
|
| 2014 |
Dunner DL, Aaronson ST, Sackeim HA, Janicak PG, Carpenter LL, Boyadjis T, Brock DG, Bonneh-Barkay D, Cook IA, Lanocha K, Solvason HB, Demitrack MA. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. The Journal of Clinical Psychiatry. 75: 1394-401. PMID 25271871 DOI: 10.4088/Jcp.13M08977 |
0.404 |
|
| 2014 |
Leuchter AF, Hunter AM, Tartter M, Cook IA. Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression. The British Journal of Psychiatry : the Journal of Mental Science. 205: 443-9. PMID 25213159 DOI: 10.1192/Bjp.Bp.113.140343 |
0.471 |
|
| 2014 |
Jain FA, Cook IA, Leuchter AF, Hunter AM, Davydov DM, Ottaviani C, Tartter M, Crump C, Shapiro D. Heart rate variability and treatment outcome in major depression: a pilot study. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 93: 204-10. PMID 24769434 DOI: 10.1016/J.Ijpsycho.2014.04.006 |
0.451 |
|
| 2014 |
Leuchter AF, McGough JJ, Korb AS, Hunter AM, Glaser PE, Deldar A, Durell TM, Cook IA. Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot project. Journal of Psychiatric Research. 54: 11-8. PMID 24726639 DOI: 10.1016/J.Jpsychires.2014.03.009 |
0.389 |
|
| 2014 |
Cook IA, Hunter AM, Korb AS, Leuchter AF. Do prefrontal midline electrodes provide unique neurophysiologic information in Major Depressive Disorder? Journal of Psychiatric Research. 53: 69-75. PMID 24630467 DOI: 10.1016/J.Jpsychires.2014.01.018 |
0.457 |
|
| 2014 |
Cook IA, Espinoza R, Leuchter AF. Neuromodulation for depression: invasive and noninvasive (deep brain stimulation, transcranial magnetic stimulation, trigeminal nerve stimulation). Neurosurgery Clinics of North America. 25: 103-16. PMID 24262903 DOI: 10.1016/J.Nec.2013.10.002 |
0.445 |
|
| 2013 |
Hunter AM, Cook IA, Abrams M, Leuchter AF. Neurophysiologic effects of repeated exposure to antidepressant medication: are brain functional changes during antidepressant administration influenced by learning processes? Medical Hypotheses. 81: 1004-11. PMID 24112999 DOI: 10.1016/J.Mehy.2013.09.016 |
0.449 |
|
| 2013 |
Janicak PG, Dunner DL, Aaronson ST, Carpenter LL, Boyadjis TA, Brock DG, Cook IA, Lanocha K, Solvason HB, Bonneh-Barkay D, Demitrack MA. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice. Cns Spectrums. 18: 322-32. PMID 23895940 DOI: 10.1017/S1092852913000357 |
0.43 |
|
| 2013 |
Cook IA, Schrader LM, Degiorgio CM, Miller PR, Maremont ER, Leuchter AF. Trigeminal nerve stimulation in major depressive disorder: acute outcomes in an open pilot study. Epilepsy & Behavior : E&B. 28: 221-6. PMID 23773978 DOI: 10.1016/J.Yebeh.2013.05.008 |
0.479 |
|
| 2013 |
Hunter AM, Leuchter AF, Power RA, Muthén B, McGrath PJ, Lewis CM, Cook IA, Garriock HA, McGuffin P, Uher R, Hamilton SP. A genome-wide association study of a sustained pattern of antidepressant response. Journal of Psychiatric Research. 47: 1157-65. PMID 23726668 DOI: 10.1016/J.Jpsychires.2013.05.002 |
0.34 |
|
| 2013 |
Hunter AM, Korb AS, Cook IA, Leuchter AF. Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication? The Journal of Neuropsychiatry and Clinical Neurosciences. 25: 126-33. PMID 23686030 DOI: 10.1176/Appi.Neuropsych.11110330 |
0.402 |
|
| 2013 |
Leuchter AF, Cook IA, Jin Y, Phillips B. The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder. Frontiers in Human Neuroscience. 7: 37. PMID 23550274 DOI: 10.3389/Fnhum.2013.00037 |
0.438 |
|
| 2013 |
Cook IA, Hunter AM, Gilmer WS, Iosifescu DV, Zisook S, Burgoyne KS, Howland RH, Trivedi MH, Jain R, Greenwald S, Leuchter AF. Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial. The Journal of Clinical Psychiatry. 74: 51-6. PMID 23419226 DOI: 10.4088/Jcp.10M06813 |
0.473 |
|
| 2013 |
DeGiorgio CM, Soss J, Cook IA, Markovic D, Gornbein J, Murray D, Oviedo S, Gordon S, Corralle-Leyva G, Kealey CP, Heck CN. Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy. Neurology. 80: 786-91. PMID 23365066 DOI: 10.1212/Wnl.0B013E318285C11A |
0.364 |
|
| 2013 |
Niederehe G, Gallagher-Thompson DE, Cook IA, Wittink MN. Personalizing Treatment for Late-Life Depression: Research Approaches American Journal of Geriatric Psychiatry. 21. DOI: 10.1016/J.Jagp.2012.12.062 |
0.385 |
|
| 2012 |
Leuchter A, Cook IA, Hunter AM. Comment on 'The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants'. Journal of Psychopharmacology (Oxford, England). 26: 1162-3; author reply. PMID 22807041 DOI: 10.1177/0269881111430732 |
0.386 |
|
| 2012 |
Carpenter LL, Janicak PG, Aaronson ST, Boyadjis T, Brock DG, Cook IA, Dunner DL, Lanocha K, Solvason HB, Demitrack MA. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depression and Anxiety. 29: 587-96. PMID 22689344 DOI: 10.1002/Da.21969 |
0.37 |
|
| 2012 |
Hunter AM, Cook IA, Leuchter AF. Does prior antidepressant treatment of major depression impact brain function during current treatment? European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 711-20. PMID 22445212 DOI: 10.1016/J.Euroneuro.2012.02.005 |
0.469 |
|
| 2012 |
Leuchter AF, Cook IA, Hunter AM, Cai C, Horvath S. Resting-state quantitative electroencephalography reveals increased neurophysiologic connectivity in depression. Plos One. 7: e32508. PMID 22384265 DOI: 10.1371/Journal.Pone.0032508 |
0.391 |
|
| 2011 |
Brody AL, Cook IA. Manipulation of cigarette craving with transcranial magnetic stimulation. Biological Psychiatry. 70: 702-3. PMID 21967985 DOI: 10.1016/J.Biopsych.2011.08.001 |
0.332 |
|
| 2011 |
Hunter AM, Cook IA, Greenwald SD, Tran ML, Miyamoto KN, Leuchter AF. The antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine. Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society. 28: 478-82. PMID 21946361 DOI: 10.1097/Wnp.0B013E318230Da8A |
0.453 |
|
| 2011 |
DeGiorgio CM, Fanselow EE, Schrader LM, Cook IA. Trigeminal nerve stimulation: seminal animal and human studies for epilepsy and depression. Neurosurgery Clinics of North America. 22: 449-56, v. PMID 21939843 DOI: 10.1016/J.Nec.2011.07.001 |
0.327 |
|
| 2011 |
Schrader LM, Cook IA, Miller PR, Maremont ER, DeGiorgio CM. Trigeminal nerve stimulation in major depressive disorder: first proof of concept in an open pilot trial. Epilepsy & Behavior : E&B. 22: 475-8. PMID 21820361 DOI: 10.1016/J.Yebeh.2011.06.026 |
0.458 |
|
| 2011 |
Bobo WV, Chen H, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, Warden D, Morris DW, Luther JF, Husain MM, Cook IA, Lesser IM, Kornstein SG, Wisniewski SR, et al. Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report. Journal of Affective Disorders. 133: 467-76. PMID 21601287 DOI: 10.1016/J.Jad.2011.04.032 |
0.444 |
|
| 2011 |
Korb AS, Hunter AM, Cook IA, Leuchter AF. Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder. Psychiatry Research. 192: 188-94. PMID 21546222 DOI: 10.1016/J.Pscychresns.2010.12.007 |
0.471 |
|
| 2011 |
Rush AJ, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, Warden D, Morris DW, Luther JF, Husain MM, Cook IA, Shelton RC, Lesser IM, Kornstein SG, Wisniewski SR. Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. The American Journal of Psychiatry. 168: 689-701. PMID 21536692 DOI: 10.1176/Appi.Ajp.2011.10111645 |
0.361 |
|
| 2011 |
McClintock SM, Husain MM, Wisniewski SR, Nierenberg AA, Stewart JW, Trivedi MH, Cook I, Morris D, Warden D, Rush AJ. Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication. Journal of Clinical Psychopharmacology. 31: 180-6. PMID 21346613 DOI: 10.1097/Jcp.0B013E31820Ebd2C |
0.405 |
|
| 2010 |
Hunter AM, Cook IA, Leuchter AF. Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of major depression. Journal of Clinical Psychopharmacology. 30: 748-51. PMID 21057245 DOI: 10.1097/Jcp.0B013E3181Faa474 |
0.451 |
|
| 2010 |
Hunter A, Bordelon Y, Cook I, Leuchter A. QEEG Measures in Huntington's Disease: A Pilot Study. Plos Currents. 2: RRN1192. PMID 21037796 DOI: 10.1371/Currents.Rrn1192 |
0.336 |
|
| 2010 |
Leuchter AF, Cook IA, Hamilton SP, Narr KL, Toga A, Hunter AM, Faull K, Whitelegge J, Andrews AM, Loo J, Way B, Nelson SF, Horvath S, Lebowitz BD. Biomarkers to predict antidepressant response. Current Psychiatry Reports. 12: 553-62. PMID 20963521 DOI: 10.1007/S11920-010-0160-4 |
0.403 |
|
| 2010 |
Townsend JD, Eberhart NK, Bookheimer SY, Eisenberger NI, Foland-Ross LC, Cook IA, Sugar CA, Altshuler LL. fMRI activation in the amygdala and the orbitofrontal cortex in unmedicated subjects with major depressive disorder. Psychiatry Research. 183: 209-17. PMID 20708906 DOI: 10.1016/J.Pscychresns.2010.06.001 |
0.407 |
|
| 2010 |
Kobak KA, Leuchter A, DeBrota D, Engelhardt N, Williams JB, Cook IA, Leon AC, Alpert J. Site versus centralized raters in a clinical depression trial: impact on patient selection and placebo response. Journal of Clinical Psychopharmacology. 30: 193-7. PMID 20520295 DOI: 10.1097/Jcp.0B013E3181D20912 |
0.406 |
|
| 2010 |
Hunter AM, Leuchter AF, Cook IA, Abrams M. Brain functional changes (QEEG cordance) and worsening suicidal ideation and mood symptoms during antidepressant treatment. Acta Psychiatrica Scandinavica. 122: 461-9. PMID 20384600 DOI: 10.1111/J.1600-0447.2010.01560.X |
0.376 |
|
| 2010 |
Farahbod H, Cook IA, Korb AS, Hunter AM, Leuchter AF. Amygdala lateralization at rest and during viewing of neutral faces in major depressive disorder using low-resolution brain electromagnetic tomography. Clinical Eeg and Neuroscience. 41: 19-23. PMID 20307012 DOI: 10.1177/155005941004100106 |
0.361 |
|
| 2010 |
Hunter AM, Muthén BO, Cook IA, Leuchter AF. Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder. Journal of Psychiatric Research. 44: 90-8. PMID 19631948 DOI: 10.1016/J.Jpsychires.2009.06.006 |
0.458 |
|
| 2010 |
Leuchter AF, Husain MM, Cook IA, Trivedi MH, Wisniewski SR, Gilmer WS, Luther JF, Fava M, Rush AJ. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report. Psychological Medicine. 40: 239-51. PMID 19493369 DOI: 10.1017/S0033291709006035 |
0.441 |
|
| 2010 |
Stewart JW, McGrath PJ, Fava M, Wisniewski SR, Zisook S, Cook I, Nierenberg AA, Trivedi MH, Balasubramani GK, Warden D, Lesser I, John Rush A. Do atypical features affect outcome in depressed outpatients treated with citalopram? The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 15-30. PMID 19341509 DOI: 10.1017/S1461145709000182 |
0.434 |
|
| 2009 |
Leuchter AF, Cook IA, Hunter AM, Korb AS. A new paradigm for the prediction of antidepressant treatment response. Dialogues in Clinical Neuroscience. 11: 435-46. PMID 20135901 |
0.332 |
|
| 2009 |
Cook IA, Hunter AM, Abrams M, Siegman B, Leuchter AF. Midline and right frontal brain function as a physiologic biomarker of remission in major depression. Psychiatry Research. 174: 152-7. PMID 19853417 DOI: 10.1016/J.Pscychresns.2009.04.011 |
0.492 |
|
| 2009 |
Leuchter AF, Cook IA, Marangell LB, Gilmer WS, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, McCracken JT, Fava M, Iosifescu D, Greenwald S. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Research. 169: 124-31. PMID 19712979 DOI: 10.1016/J.Psychres.2009.06.004 |
0.454 |
|
| 2009 |
Leuchter AF, Cook IA, Gilmer WS, Marangell LB, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, Fava M, Iosifescu D, Greenwald S. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Research. 169: 132-8. PMID 19709754 DOI: 10.1016/J.Psychres.2009.04.004 |
0.443 |
|
| 2009 |
Leuchter AF, McCracken JT, Hunter AM, Cook IA, Alpert JE. Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. Journal of Clinical Psychopharmacology. 29: 372-7. PMID 19593178 DOI: 10.1097/Jcp.0B013E3181Ac4Aaf |
0.362 |
|
| 2009 |
Korb AS, Hunter AM, Cook IA, Leuchter AF. Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 120: 1313-9. PMID 19539524 DOI: 10.1016/J.Clinph.2009.05.008 |
0.366 |
|
| 2009 |
Leuchter AF, Cook IA, Hunter A, Korb A. Use of clinical neurophysiology for the selection of medication in the treatment of major depressive disorder: the state of the evidence. Clinical Eeg and Neuroscience. 40: 78-83. PMID 19534301 DOI: 10.1177/155005940904000207 |
0.408 |
|
| 2009 |
Hunter AM, Leuchter AF, Cook IA, Abrams M, Siegman BE, Furst DE, Chappell AS. Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study. Pain Medicine (Malden, Mass.). 10: 730-8. PMID 19453962 DOI: 10.1111/J.1526-4637.2009.00614.X |
0.456 |
|
| 2009 |
Hunter AM, Ravikumar S, Cook IA, Leuchter AF. Brain functional changes during placebo lead-in and changes in specific symptoms during pharmacotherapy for major depression. Acta Psychiatrica Scandinavica. 119: 266-73. PMID 19077131 DOI: 10.1111/J.1600-0447.2008.01305.X |
0.442 |
|
| 2008 |
Leuchter AF, Cook IA, DeBrota DJ, Hunter AM, Potter WZ, McGrouther CC, Morgan ML, Abrams M, Siegman B. Changes in brain function during administration of venlafaxine or placebo to normal subjects. Clinical Eeg and Neuroscience. 39: 175-81. PMID 19044214 DOI: 10.1177/155005940803900405 |
0.394 |
|
| 2008 |
Lesser I, Rosales A, Zisook S, Gonzalez C, Flores D, Trivedi M, Sciolla A, Luther J, Wisniewski S, Alpert J, Cook I, Rush AJ, Epstein M. Depression outcomes of Spanish- and english-speaking Hispanic outpatients in STAR*D. Psychiatric Services (Washington, D.C.). 59: 1273-84. PMID 18971403 DOI: 10.1176/Appi.Ps.59.11.1273 |
0.38 |
|
| 2008 |
Korb AS, Cook IA, Hunter AM, Leuchter AF. Brain electrical source differences between depressed subjects and healthy controls. Brain Topography. 21: 138-46. PMID 18958615 DOI: 10.1007/S10548-008-0070-5 |
0.398 |
|
| 2007 |
Shapiro D, Cook IA, Davydov DM, Ottaviani C, Leuchter AF, Abrams M. Yoga as a complementary treatment of depression: effects of traits and moods on treatment outcome. Evidence-Based Complementary and Alternative Medicine : Ecam. 4: 493-502. PMID 18227917 DOI: 10.1093/ecam/nel114 |
0.317 |
|
| 2007 |
Hunter AM, Cook IA, Leuchter AF. The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder. The Psychiatric Clinics of North America. 30: 105-24. PMID 17362807 DOI: 10.1016/J.Psc.2006.12.002 |
0.484 |
|
| 2007 |
Cook IA, Balasubramani GK, Eng H, Friedman E, Young EA, Martin J, Nay WT, Ritz L, Rush AJ, Stegman D, Warden D, Trivedi MH, Wisniewski SR. Electronic source materials in clinical research: acceptability and validity of symptom self-rating in major depressive disorder. Journal of Psychiatric Research. 41: 737-43. PMID 17275840 DOI: 10.1016/J.Jpsychires.2006.07.015 |
0.328 |
|
| 2007 |
Davydov DM, Shapiro D, Cook IA, Goldstein I. Baroreflex mechanisms in major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 31: 164-77. PMID 17011098 DOI: 10.1016/J.Pnpbp.2006.08.015 |
0.371 |
|
| 2007 |
Morgan ML, Cook IA, Rapkin AJ, Leuchter AF. Neurophysiologic changes during estrogen augmentation in perimenopausal depression. Maturitas. 56: 54-60. PMID 16835012 DOI: 10.1016/J.Maturitas.2006.05.010 |
0.425 |
|
| 2007 |
Leuchter A, Cook I, Marangell L, Gilmer W, Burgoyne K, Howland R, Trivedi M, Zisook S, Fava M, Manberg P. P.2.g.007 Biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) European Neuropsychopharmacology. 17: S394-S395. DOI: 10.1016/S0924-977X(07)70587-4 |
0.406 |
|
| 2006 |
Hunter AM, Leuchter AF, Morgan ML, Cook IA. Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. The American Journal of Psychiatry. 163: 1426-32. PMID 16877657 DOI: 10.1176/Ajp.2006.163.8.1426 |
0.465 |
|
| 2006 |
Venneman S, Leuchter A, Bartzokis G, Beckson M, Simon SL, Schaefer M, Rawson R, Newton T, Cook IA, Uijtdehaage S, Ling W. Variation in neurophysiological function and evidence of quantitative electroencephalogram discordance: predicting cocaine-dependent treatment attrition. The Journal of Neuropsychiatry and Clinical Neurosciences. 18: 208-16. PMID 16720798 DOI: 10.1176/Jnp.2006.18.2.208 |
0.353 |
|
| 2006 |
Moses T, Leuchter AF, Cook I, Abrams M. Does the clinical course of depression determine improvement in symptoms and quality of life? The Journal of Nervous and Mental Disease. 194: 241-8. PMID 16614544 DOI: 10.1097/01.Nmd.0000207358.15230.80 |
0.415 |
|
| 2005 |
Krell HV, Leuchter AF, Cook IA, Abrams M. Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain. Psychosomatics. 46: 379-84. PMID 16145181 DOI: 10.1176/Appi.Psy.46.5.379 |
0.334 |
|
| 2005 |
Novick JS, Stewart JW, Wisniewski SR, Cook IA, Manev R, Nierenberg AA, Rosenbaum JF, Shores-Wilson K, Balasubramani GK, Biggs MM, Zisook S, Rush AJ. Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. The Journal of Clinical Psychiatry. 66: 1002-11. PMID 16086615 DOI: 10.4088/Jcp.V66N0807 |
0.42 |
|
| 2005 |
Cook IA, Leuchter AF, Morgan ML, Stubbeman W, Siegman B, Abrams M. Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. Journal of Psychiatric Research. 39: 461-6. PMID 15992554 DOI: 10.1016/J.Jpsychires.2004.12.002 |
0.465 |
|
| 2005 |
Morgan ML, Witte EA, Cook IA, Leuchter AF, Abrams M, Siegman B. Influence of age, gender, health status, and depression on quantitative EEG. Neuropsychobiology. 52: 71-6. PMID 15990459 DOI: 10.1159/000086608 |
0.424 |
|
| 2005 |
Morgan ML, Cook IA, Rapkin AJ, Leuchter AF. Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study. The Journal of Clinical Psychiatry. 66: 774-80. PMID 15960574 DOI: 10.4088/Jcp.V66N0617 |
0.41 |
|
| 2005 |
Hunter AM, Leuchter AF, Morgan ML, Cook IA, Abrams M, Siegman B, DeBrota DJ, Potter WZ. Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 792-9. PMID 15637637 DOI: 10.1038/Sj.Npp.1300652 |
0.389 |
|
| 2004 |
Krell HV, Leuchter AF, Morgan M, Cook IA, Abrams M. Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant. The Journal of Clinical Psychiatry. 65: 1174-9. PMID 15367043 DOI: 10.4088/Jcp.V65N0904 |
0.373 |
|
| 2004 |
Stubbeman WF, Leuchter AF, Cook IA, Shurman BD, Morgan M, Gunay I, Gonzalez S. Pretreatment neurophysiologic function and ECT response in depression. The Journal of Ect. 20: 142-4. PMID 15342997 DOI: 10.1097/00124509-200409000-00004 |
0.44 |
|
| 2004 |
Leuchter AF, Morgan M, Cook IA, Dunkin J, Abrams M, Witte E. Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression. Psychopharmacology. 177: 15-22. PMID 15252704 DOI: 10.1007/S00213-004-1919-2 |
0.446 |
|
| 2004 |
Cook IA, Leuchter AF, Morgan ML, Dunkin JJ, Witte E, David S, Mickes L, O'Hara R, Simon S, Lufkin R, Abrams M, Rosenberg S. Longitudinal progression of subclinical structural brain disease in normal aging. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 12: 190-200. PMID 15010348 DOI: 10.1097/00019442-200403000-00010 |
0.309 |
|
| 2004 |
Newton TF, Kalechstein AD, Hardy DJ, Cook IA, Nestor L, Ling W, Leuchter AF. Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 115: 194-8. PMID 14706488 DOI: 10.1016/S1388-2457(03)00314-6 |
0.311 |
|
| 2003 |
Newton TF, Cook IA, Kalechstein AD, Duran S, Monroy F, Ling W, Leuchter AF. Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 114: 410-5. PMID 12705421 DOI: 10.1016/S1388-2457(02)00409-1 |
0.325 |
|
| 2002 |
Cook IA, Leuchter AF, Morgan ML, Conlee EW, David S, Lufkin R, Babaie A, Dunkin JJ, O'Hara R, Simon S, Lightner A, Thomas S, Broumandi D, Badjatia N, Mickes L, et al. Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjects. Archives of Neurology. 59: 1612-20. PMID 12374500 DOI: 10.1001/Archneur.59.10.1612 |
0.301 |
|
| 2002 |
Cook IA, Leuchter AF, Morgan M, Witte E, Stubbeman WF, Abrams M, Rosenberg S, Uijtdehaage SH. Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 120-31. PMID 12062912 DOI: 10.1016/S0893-133X(02)00294-4 |
0.432 |
|
| 2002 |
Unützer J, Choi Y, Cook IA, Oishi S. A web-based data management system to improve care for depression in a multicenter clinical trial. Psychiatric Services (Washington, D.C.). 53: 671-3, 678. PMID 12045303 DOI: 10.1176/Ps.53.6.671 |
0.352 |
|
| 2002 |
Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M. Changes in brain function of depressed subjects during treatment with placebo. The American Journal of Psychiatry. 159: 122-9. PMID 11772700 DOI: 10.1176/Appi.Ajp.159.1.122 |
0.453 |
|
| 2001 |
Cook IA, Leuchter AF. Prefrontal changes and treatment response prediction in depression Seminars in Clinical Neuropsychiatry. 6: 113-120. PMID 11296311 DOI: 10.1053/Scnp.2001.21844 |
0.498 |
|
| 2000 |
Dunkin JJ, Leuchter AF, Cook IA, Kasl-Godley JE, Abrams M, Rosenberg-Thompson S. Executive dysfunction predicts nonresponse to fluoxetine in major depression. Journal of Affective Disorders. 60: 13-23. PMID 10940443 DOI: 10.1016/S0165-0327(99)00157-3 |
0.439 |
|
| 1999 |
Leuchter AF, Uijtdehaage SHJ, Cook IA, O'Hara R, Mandelkern M. Relationship between brain electrical activity and cortical perfusion in normal subjects Psychiatry Research - Neuroimaging. 90: 125-140. PMID 10482384 DOI: 10.1016/S0925-4927(99)00006-2 |
0.317 |
|
| 1999 |
Cook IA, Leuchter AF, Witte E, Abrams M, Uijtdehaage SHJ, Stubbeman W, Rosenberg-Thompson S, Anderson-Hanley C. Neurophysiologic predictors of treatment response to fluoxetine in major depression Psychiatry Research. 85: 263-273. PMID 10333379 DOI: 10.1016/S0165-1781(99)00010-4 |
0.414 |
|
| 1998 |
Cook IA, Leuchter AF, Uijtdehaage SHJ, Osato S, Holschneider DH, Abrams M, Rosenberg-Thompson S. Altered cerebral energy utilization in late life depression Journal of Affective Disorders. 49: 89-99. PMID 9609672 DOI: 10.1016/S0165-0327(97)00192-4 |
0.444 |
|
| 1997 |
Leuchter AF, Cook IA, Uijtdehaage SHJ, Dunkin J, Lufkin RB, Anderson-Hanley C, Abrams M, Rosenberg-Thompson S, O'Hara R, Simon SL, Osato S, Babaie A. Brain structure and function and the outcomes of treatment for depression Journal of Clinical Psychiatry. 58: 22-31. PMID 9430506 |
0.38 |
|
| 1994 |
Leuchter A, Simon SL, Daly KA, Abrams M, Rosenberg-Thompson S, Dunkin JJ, Cook IA, Newton TF, Spar JE. Quantitative EEG Correlates of Outcome in Older Psychiatric Patients: Part II: Two-Year Follow-Up of Patients With Depression. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 2: 290-299. PMID 28530979 DOI: 10.1097/00019442-199402040-00004 |
0.413 |
|
| 1994 |
Leuchter A, Simon SL, Daly KA, Rosenberg-Thompson S, Abrams M, Dunkin JJ, Cook IA, Newton TF, Walter DO, Cummings JL. Quantitative EEG Correlates of Outcome in Older Psychiatric Patients: Part I: Cross-Sectional and Longitudinal Assessment of Patients With Dementia. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 2: 200-209. PMID 28530933 DOI: 10.1097/00019442-199400230-00004 |
0.322 |
|
| 1994 |
Leuchter AF, Dunkin JJ, Lufkin RB, Anzai Y, Cook IA, Newton TF. Effect of white matter disease on functional connections in the aging brain. Journal of Neurology, Neurosurgery, and Psychiatry. 57: 1347-54. PMID 7964810 DOI: 10.1136/Jnnp.57.11.1347 |
0.313 |
|
| 1993 |
Leuchter AF, Cook IA, Newton TF, Dunkin J, Walter DO, Rosenberg-Thompson S, Lachenbruch PA, Weiner H. Regional differences in brain electrical activity in dementia: use of spectral power and spectral ratio measures. Electroencephalography and Clinical Neurophysiology. 87: 385-93. PMID 7508371 DOI: 10.1016/0013-4694(93)90152-L |
0.316 |
|
| 1992 |
Leuchter AF, Newton TF, Cook IA, Walter DO, Rosenberg-Thompson S, Lachenbruch PA. Changes in brain functional connectivity in Alzheimer-type and multi-infarct dementia. Brain : a Journal of Neurology. 115: 1543-61. PMID 1422803 DOI: 10.1093/Brain/115.5.1543 |
0.313 |
|
| Show low-probability matches. |